latestmarketingreports

Respiratory Disease Testing/Diagnostics Market size in 2019 is estimated to be $5.9 billion, growing at a CAGR of 5% during the forecast period 2020-2025. Respiratory disease is the disease that affects the lungs and respiratory system. It is caused by infection, smoking tobacco, or air pollution. Asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are some of the major respiratory diseases. The growing geriatric population with respiratory disorders and technological advancement in respiratory diagnostic testing are the major factors driving the growth of the market. Moreover, increasing prevalence of respiratory disease linked to increased rates of tobacco smoking is set to further influence the overall market growth for respiratory disease testing/diagnostics. Key Takeaways In 2019, North America dominated the respiratory disease testing/diagnostics market owing to the growing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease...